Recombinant Mycoplasma genitalium ATP synthase subunit c (atpE) is a bioengineered protein derived from the F₀ sector of the ATP synthase complex. It plays a critical role in proton translocation across mitochondrial membranes in eukaryotes and bacterial bioenergetic processes. In M. genitalium, this protein is essential for ATP production via glycolysis, as the bacterium lacks respiratory chains and relies solely on fermentation for energy .
The recombinant form is produced in E. coli with a His-tag for purification, spanning the full-length sequence (1–102 amino acids) . While structural data for M. genitalium atpE is limited, studies on homologous proteins (e.g., human and yeast subunit c) reveal a conserved cylindrical structure critical for proton pumping .
The recombinant atpE is expressed in E. coli under optimized conditions for solubility. Key steps include:
Cloning: Insertion of the atpE gene into a plasmid vector (e.g., pET series) with a His-tag.
Induction: IPTG-induced overexpression at 16–20°C to reduce inclusion body formation .
Purification:
Ni²⁺ affinity chromatography: Binds His-tagged protein.
Size-exclusion chromatography: Ensures monodispersity.
| Parameter | Specification | Method |
|---|---|---|
| Purity | >90% (SDS-PAGE) | Coomassie staining |
| Concentration | 0.1–1.0 mg/mL (reconstituted in deionized water) | Bradford assay |
| Storage | -20°C/-80°C (lyophilized powder) | Aliquoting recommended |
Data from commercial suppliers indicate high yield and stability, making it suitable for structural studies or functional assays .
In M. genitalium, ATP synthase is critical for survival due to its reliance on glycolysis . Recombinant atpE could elucidate:
Proton-translocating efficiency: Mutagenesis studies to map critical residues.
Drug targets: Screening inhibitors of ATP synthase to combat antibiotic-resistant strains.
Limited Functional Data: Most studies focus on eukaryotic or other bacterial systems (e.g., E. coli, Enterococcus).
Antigenic Potential: M. genitalium’s atpE may evade host immunity due to low homology with human proteins, making it a candidate for vaccine development .
Therapeutic Targeting: Inhibiting ATP synthase could disrupt M. genitalium’s energy metabolism, but requires further validation .
KEGG: mge:MG_404
STRING: 243273.MgenG_010200000470